Clinical Trials Sponsored by ImThera Medical, Inc

Total 2859 results

ImThera Medical, Inc.

Completed

Targeted Hypoglossal Neurostimulation Study #2 (THN2)

Sleep Apnea Syndromes | Sleep Apnea, Obstructive | Respiration Disorders | Signs and Symptoms, Respiratory | Syndrome, Obstructive Sleep Apnea

United States, France, Belgium, Germany, Italy
ImThera Medical, Inc.
LivaNova

Completed

Targeted Hypoglossal Neurostimulation Study #3 (THN3)

Obstructive Sleep Apnea

United States, Israel, France, Belgium, Germany, Portugal
ImThera Medical, Inc.

Completed

Safety and Efficacy of a Hypoglossal Nerve Implant for the Treatment of Obstructive Sleep Apnea (OSA)

Sleep Apnea Syndromes | Sleep Apnea, Obstructive | Respiration Disorders | Signs and Symptoms, Respiratory | Syndrome, Obstructive Sleep Apnea

Belgium
AstraZeneca
Medpace, Inc.; Omthera Pharmaceuticals, Inc

Completed

[E]PANOVA Combined With a [S]TATIN in [P]ATIENTS With HYPERT[R]IGLYCER[I]DEMIA to Reduce Non-HDL CHOLES[T]EROL (ESPRIT)

Cardiovascular Disease | Hypertriglyceridemia

United States
Cothera Bioscience, Inc

Recruiting

Sepantronium Bromide for the Treatment of High-grade B-cell Lymphoma

Lymphoma, B-Cell | Lymphoma, Large B-Cell, Diffuse | Lymphatic Diseases | Burkitt Lymphoma | High-grade B-cell Lymphoma | C-MYC/BCL6 Double-Hit High-Grade B-Cell Lymphoma | C-MYC/BCL2 Double-Hit High-Grade B-Cell Lymphoma | Lymphoma, High-Grade | C-Myc Gene Rearrangement

Korea, Republic of, China
ExThera Medical Corporation

Completed

Safety Evaluation of Seraph® 100 to Reduce Bacteremia in Patients on Hemodialysis

Bacteremia | Bacterial Infection

Germany
iThera Medical GmbH
European Commission

Suspended

Enhancing Ultrasound & Photoacoustic for Recognition of Intestinal Abnormalities (EUPHORIA)

Inflammatory Bowel Diseases | Crohn Disease | Ulcerative Colitis

Germany, Italy
Ulthera, Inc

Completed

Evaluation of the Ulthera System for Treating Axillary Hyperhidrosis (ULT-218)

Axillary Hyperhidrosis

Germany
Ulthera, Inc

Completed

Ultherapy® for Treating the Face and Neck Using Standard Versus Simulines Transducers

Skin Laxity

United States
Ulthera, Inc

Completed

Clinical Study on the Application of a Non-Invasive Micro-Focused Ultrasound With Visualization System for Skin Laxity (ULT-215) (ULT-215)

Facial Skin Laxity
Ulthera, Inc

Completed

Ultherapy® for the Treatment of Erythematotelangiectatic Rosacea

Rosacea | Erythematotelangiectatic Rosacea

United States, Canada
Ulthera, Inc

Completed

Ultherapy for Buttock Lift

Buttock Ptosis

United States
Ulthera, Inc

Completed

Feasibility Study: Evaluation of the Treatment of Striae Using Ultherapy® in Combination With Laser Treatment

Scars | Striae

United States
Ulthera, Inc

Completed

Histological Analysis Following Ulthera System Treatment for Hyperhidrosis

Hyperhidrosis

United States
Ulthera, Inc

Completed

Lifting and Tightening of the Face and Neck Utilizing the Ulthera® System

Facial and Neck Skin Laxity

United States
Ulthera, Inc

Completed

Feasibility Study: Heavy Water Tissue Labeling Protocol

Skin Laxity

United States
Ulthera, Inc

Completed

Feasibility Study: Compare the Effectiveness Between Two Pain Medications When Used Prior to Ultherapy™ Treatments

Skin Laxity

United States
Ulthera, Inc

Completed

Feasibility Study: Higher Density Ulthera® System Treatment With Vectoring for Treatment of the Face and Neck

Skin Laxity

United States
Ulthera, Inc

Completed

Feasibility Study: Lifting and Tightening of the Elbows

Skin Laxity

United States
Ulthera, Inc

Completed

Retrospective Evaluation of Combination Treatment With the Ulthera System

Skin Laxity

United States
Ulthera, Inc

Completed

Feasibility Study: Ulthera Treatment of the Buttocks and Thighs

Skin Laxity

United States
Ulthera, Inc

Completed

Feasibility Study: Evaluation of the Ulthera® System for Treatment of the Knees

Skin Laxity

United States
Ulthera, Inc

Completed

Feasibility Study: Safety and Efficacy of the Ulthera® System for Treatment of Axillary Hyperhidrosis

Hyperhidrosis

United States
Ulthera, Inc

Completed

Evaluation of the Effectiveness and Safety of the Ulthera™ System for the Treatment of Wrinkles Around the Eyes

Periorbital Wrinkles

United States
ExThera Medical Europe BV
ExThera Medical Corporation; Vivantes Clinic Neukölln

Recruiting

Safety & Effectiveness Evaluation of Seraph 100 in Treatment of Pts With COVID-19 (CP022)

COVID-19

Spain, Germany
Merz North America, Inc.
Ulthera, Inc

Completed

A Study of Octave System for Improving Lines and Wrinkles of the Décolleté

Décolleté Wrinkles

United States
Ulthera, Inc

Terminated

Simulines Non-Inferiority Pivotal Study

Skin Laxity

United States
Merz North America, Inc.
Ulthera, Inc

Completed

Study of the Cabochon System for Improvement in the Appearance of Cellulite

Gynoid Lipodystrophy

United States
Ulthera, Inc

Completed

A Retrospective Study to Evaluate the Effectiveness of the Ulthera System

Wrinkles | Skin Laxity

United States
Ulthera, Inc

Completed

Ulthera® System for Treating Axillary Hyperhidrosis

Primary Axillary Hyperhidrosis

United States
Ulthera, Inc

Completed

Reducing Wrinkles Around the Eyes Using the Ulthera® System

Periorbital Wrinkles

United States
Ulthera, Inc

Completed

Treatment of the Face and Neck With Lower Ulthera System Energy Settings

Skin Laxity

United States
Ulthera, Inc

Completed

Evaluation of the Ulthera® System for Treatment of the Brachia

Brachial Ptosis

United States
Ulthera, Inc

Completed

Feasibility Study: Evaluate the Effectiveness of Using a Topical Anesthetic Prior to Ultherapy™ Treatment

Skin Laxity

United States
Ulthera, Inc

Completed

Feasibility Study: Lifting and Tightening Neck Skin in Patients

Skin Laxity

United States
Ulthera, Inc

Completed

Feasibility Study: Ulthera System for the Treatment of Rosacea

Erythematotelangiectatic Rosacea

Canada
Ulthera, Inc

Completed

Feasibility Study: Ulthera® System for the Treatment of Axillary Hyperhidrosis

Hyperhidrosis

United States
Ulthera, Inc

Terminated

Feasibility Study: Histological Characterization After Treatment With the Ulthera® System

Skin Laxity

United States
Merz North America, Inc.
Ulthera, Inc

Completed

Evaluation of the Effectiveness and Safety of the Ulthera® DeepSEE® System for Treating Skin Laxity in the Lower Face and Submentum

Improvement in Skin Laxity of the Lower Face and Submentum

China
Merz North America, Inc.
Ulthera, Inc

Completed

Open-label, Prospective Evaluation of the Ulthera® System for Lifting Submental (Under the Chin) and Neck Tissue in Chinese Patients (ULT-302)

Mild to Moderate Skin Laxity Under the Chin | Mild to Moderate Skin Laxity on Neck

United States
Ulthera, Inc

Completed

Evaluation of the Ulthera® System and Efficacy Correlation to Morphological Differences

Facial and Neck Skin Laxity

United States
Ulthera, Inc

Terminated

Gene Expression Following Ultherapy® Treatment

Skin Laxity

United States
Ulthera, Inc

Completed

Ultherapy for the Treatment of Spider Veins on the Legs

Spider Veins | Telangiectasia

United States
Ulthera, Inc

Completed

Ultherapy® for the Treatment of Acne Scars

Acne Scars | Atrophic Acne Scars

United States
Ulthera, Inc

Completed

Ultherapy™ Treatment Following Sculptra® Treatment

Skin Laxity

United States
Ulthera, Inc

Completed

Lifting and Tightening of the Face in Subjects With Skin of Darker Color

Facial Skin Laxity

United States
Ulthera, Inc

Completed

Lifting and Tightening of the Face and Neck Following an Increased Density Treatment

Skin Laxity

United States
Ulthera, Inc

Completed

Evaluation of the Ulthera System for the Treatment of the Decolletage

Chest Wrinkles

United States
Ulthera, Inc

Completed

Feasibility Study: Evaluation of Ulthera Versus Thermage for Treating the Face and Neck

Wrinkles | Skin Laxity

United States
Ulthera, Inc

Terminated

Peri-orbital and Peri-oral Wrinkle Reduction Trial

Peri-oral Wrinkles | Peri-orbital Wrinkles

United States

Clinical Trials Sponsored by ImThera Medical, Inc

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bahrain

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations